Qiagen Nv share price today

(QGEN)

Qiagen Nv share price is $43.77 & ₹3,707.28

$43.77

▲

0.48

(1.11%)

Market is closed - opens 8 PM, 05 Dec 2024

View live Qiagen Nv share price in Dollar and Rupees. Guide to invest in Qiagen Nv from India. Also see the sentimental analysis on Indian investors investing in Qiagen Nv. Get details on the Indian mutual funds that are investing in Qiagen Nv. Get Analyst recommendations and forecasts along with all the Qiagen Nv's financials.

Qiagen Nv share price movements

$43.24
$43.94
$43.77
1.21%
Downside
Day's Volatility :1.59%
Upside
0.39%
$39.03
$47.44
$43.77
10.83%
Downside
52 Weeks Volatility :17.73%
Upside
7.74%

Qiagen Nv Returns

Period	Qiagen Nv	Sector (Health Care)	Index (Russel 2000)
3 Months	-1.87%	-6.1%	0.0%
6 Months	-2.85%	1.4%	0.0%
1 Year	2.14%	11.4%	0.0%
3 Years	-20.71%	12.9%	-18.1%

Qiagen Nv Key Statistics

in dollars & INR

Market Capitalization	$9.7B
Revenue TTM	$2.0B
EBITDA	$669.6M
Earnings Per Share (EPS)	$0.45
PE Ratio	96.51
Dividend Yield	2.94%
Profit Margin	4.73%
Quarterly Earnings Growth YOY	0.26%
Return On Equity TTM	2.57%

How to invest in Qiagen Nv from India?

It is very easy for Indian residents to invest directly in Qiagen Nv from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Qiagen Nv stock in both rupees (INR) and dollars (USD). Search for Qiagen Nv or QGEN on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Qiagen Nv or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Qiagen Nv shares which would translate to 0.019 fractional shares of Qiagen Nv as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Qiagen Nv

Period: Sep 5, 2024 to Dec 4, 2024. Change in 30 Days versus previous period

Search volume for Qiagen Nv on INDmoney from India has grown in the last 30 days as on Dec 5, 2024. 0% more investors are searching Qiagen Nv in the last 30 days versus the previous period.

Global Institutional Holdings in Qiagen Nv

Massachusetts Financial Services Company
10.40%
Wellington Management Company LLP
9.56%
Vanguard Group Inc
3.96%
BlackRock Inc
3.43%
Amundi
2.63%
Mariner Value Strategies, LLC
2.02%

Analyst Recommendation on Qiagen Nv

Buy

60%Buy

40%Hold

0%Sell

Based on 25 Wall street analysts offering stock ratings for Qiagen Nv(by analysts ranked 0 to 5 stars)

Based on 25 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Qiagen Nv

What analysts predicted

Upside of 15.57%

Current:

$43.77

Target:

$50.59

Insights on Qiagen Nv

Increasing Revenue
Revenue is up for the last 3 quarters, 458.79M → 501.86M (in $), with an average increase of 4.3% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -183.46M → 98.05M (in $), with an average increase of 287.1% per quarter
Vs DHR
In the last 1 year, Danaher Corp. has given 8.6% return, outperforming this stock by 6.6%

Qiagen Nv Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$1.5B	↑ 5.95%
Net Income	$190.4M	↑ 371.31%
Net Profit Margin	12.68%	↑ 9.83%

	FY19	Y/Y Change
Revenue	$1.5B	↑ 1.64%
Net Income	$-41.5M	↓ 121.77%
Net Profit Margin	-2.72%	↓ 15.4%

	FY20	Y/Y Change
Revenue	$1.9B	↑ 22.53%
Net Income	$73.6M	↓ 277.64%
Net Profit Margin	3.94%	↑ 6.66%

	FY21	Y/Y Change
Revenue	$2.3B	↑ 20.39%
Net Income	$512.6M	↑ 596.09%
Net Profit Margin	22.77%	↑ 18.83%

	FY22	Y/Y Change
Revenue	$2.1B	↓ 4.89%
Net Income	$423.2M	↓ 17.44%
Net Profit Margin	19.76%	↓ 3.01%

	FY23	Y/Y Change
Revenue	$2.0B	↓ 8.23%
Net Income	$341.3M	↓ 19.35%
Net Profit Margin	17.37%	↓ 2.39%

	Q2 FY23	Q/Q Change
Revenue	$494.9M	↑ 1.95%
Net Income	$80.8M	↓ 5.0%
Net Profit Margin	16.33%	↓ 1.19%

	Q3 FY23	Q/Q Change
Revenue	$475.9M	↓ 3.83%
Net Income	$77.8M	↓ 3.67%
Net Profit Margin	16.35%	↑ 0.02%

	Q4 FY23	Q/Q Change
Revenue	$509.2M	↑ 6.99%
Net Income	$97.7M	↑ 25.5%
Net Profit Margin	19.18%	↑ 2.83%

	Q1 FY24	Q/Q Change
Revenue	$458.8M	↓ 9.89%
Net Income	$80.7M	↓ 17.4%
Net Profit Margin	17.58%	↓ 1.6%

	Q2 FY24	Q/Q Change
Revenue	$496.3M	↑ 8.18%
Net Income	$-183.5M	↓ 327.41%
Net Profit Margin	-36.96%	↓ 54.54%

	Q3 FY24	Q/Q Change
Revenue	$501.9M	↑ 1.11%
Net Income	$98.1M	↓ 153.45%
Net Profit Margin	19.54%	↑ 56.5%

	FY18	Y/Y Change
Total Assets	$5.7B	↑ 14.09%
Total Liabilities	$3.1B	↑ 24.66%

	FY19	Y/Y Change
Total Assets	$5.2B	↓ 8.92%
Total Liabilities	$2.7B	↓ 13.31%

	FY20	Y/Y Change
Total Assets	$6.0B	↑ 14.05%
Total Liabilities	$3.5B	↑ 29.24%

	FY21	Y/Y Change
Total Assets	$6.1B	↑ 2.94%
Total Liabilities	$3.1B	↓ 12.55%

	FY22	Y/Y Change
Total Assets	$6.3B	↑ 2.29%
Total Liabilities	$2.8B	↓ 7.52%

	FY23	Y/Y Change
Total Assets	$6.1B	↓ 2.74%
Total Liabilities	$2.3B	↓ 18.21%

	Q2 FY23	Q/Q Change
Total Assets	$6.3B	↑ 1.09%
Total Liabilities	$2.7B	↑ 0.22%

	Q3 FY23	Q/Q Change
Total Assets	$5.9B	↓ 6.94%
Total Liabilities	$2.2B	↓ 18.75%

	Q4 FY23	Q/Q Change
Total Assets	$6.1B	↑ 3.53%
Total Liabilities	$2.3B	↑ 4.27%

	Q1 FY24	Q/Q Change
Total Assets	$5.8B	↓ 5.06%
Total Liabilities	$2.2B	↓ 4.38%

	Q2 FY24	Q/Q Change
Total Assets	$5.6B	↓ 3.81%
Total Liabilities	$2.2B	↓ 1.22%

	Q3 FY24	Q/Q Change
Total Assets	$6.3B	↑ 12.28%
Total Liabilities	$2.7B	↑ 25.73%

	FY18	Y/Y Change
Operating Cash Flow	$359.5M	↑ 25.36%
Investing Cash Flow	$-211.4M	↓ 54.48%
Financing Cash Flow	$360.4M	↓ 6.92%

	FY19	Y/Y Change
Operating Cash Flow	$330.8M	↓ 7.97%
Investing Cash Flow	$-222.3M	↑ 5.17%
Financing Cash Flow	$-639.1M	↓ 277.32%

	FY20	Y/Y Change
Operating Cash Flow	$492.3M	↑ 48.79%
Investing Cash Flow	$-443.3M	↑ 99.43%
Financing Cash Flow	$-74.3M	↓ 88.37%

	FY21	Y/Y Change
Operating Cash Flow	$639.0M	↑ 29.81%
Investing Cash Flow	$-202.4M	↓ 54.33%
Financing Cash Flow	$-150.4M	↑ 102.32%

	FY22	Y/Y Change
Operating Cash Flow	$715.3M	↑ 11.93%
Investing Cash Flow	$-735.6M	↑ 263.38%
Financing Cash Flow	$-125.8M	↓ 16.34%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$111.5M	↑ 54.99%
Investing Cash Flow	$156.3M	↑ 0.0%
Financing Cash Flow	$-15.5M	↑ 57.43%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$124.7M	↑ 11.85%
Investing Cash Flow	$248.4M	↑ 58.93%
Financing Cash Flow	$-401.1M	↑ 2492.37%

Qiagen Nv Technicals Summary

Sell

Neutral

Buy

Qiagen Nv is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Qiagen Nv Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Qiagen Nv	-0.68%	-2.85%	2.14%	-20.71%	1.94%
Idexx Laboratories, Inc.	3.92%	-13.47%	-17.41%	-27.26%	72.99%
Agilent Technologies Inc.	-0.05%	5.09%	8.28%	-7.85%	71.01%
Thermo Fisher Scientific, Inc.	-4.59%	-8.6%	7.32%	-14.83%	67.48%
Danaher Corp.	-2.38%	-9.96%	9.3%	-21.38%	63.55%
Iqvia Holdings Inc.	-4.0%	-8.48%	-6.4%	-23.3%	37.83%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Qiagen Nv	96.51	96.51	1.0	2.18	0.03	0.05	0.03	15.88
Idexx Laboratories, Inc.	40.63	40.63	4.44	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	31.14	31.14	2.34	5.24	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	33.23	33.23	2.02	21.69	0.13	0.05	0.0	128.08
Danaher Corp.	45.22	45.22	3.2	7.5	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	26.47	26.47	1.04	11.13	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Qiagen Nv	Buy	$9.7B	1.94%	96.51	4.73%
Idexx Laboratories, Inc.	Buy	$34.5B	72.99%	40.63	22.53%
Agilent Technologies Inc.	Buy	$39.4B	71.01%	31.14	21.75%
Thermo Fisher Scientific, Inc.	Buy	$202.6B	67.48%	33.23	14.48%
Danaher Corp.	Buy	$173.1B	63.55%	45.22	16.39%
Iqvia Holdings Inc.	Buy	$36.6B	37.83%	26.47	9.17%

Qiagen Nv Dividend announcements

Qiagen Nv Dividends March, 2024
In the quarter ending March,2024. Qiagen Nv has declared dividend of $1.28
Read More

About Qiagen Nv

qiagen is the leading global provider of sample to insight solutions to transform biological materials into valuable molecular insights. qiagen sample technologies isolate and process dna, rna and proteins from blood, tissue and other materials. assay technologies make these biomolecules visible and ready for analysis. bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. automation solutions tie these together in seamless and cost-effective molecular testing workflows. qiagen provides these workflows to more than 500,000 customers around the world in molecular diagnostics (human healthcare), applied testing (forensics, veterinary testing and food safety), pharma (pharmaceutical and biotechnology companies) and academia (life sciences research). as of june 30, 2015, qiagen employed approximately 4,400 people in over 35 locations worldwide. further information can be found at http://www.qiagen.com.

Organization	Qiagen Nv
Employees	5800
CEO	Mr. Thierry Bernard
Industry	Health Technology

Important FAQs about investing in Qiagen Nv from India :

What is Qiagen Nv share price today?

Qiagen Nv (QGEN) share price today is $43.77.

Can Indians buy Qiagen Nv shares?

Yes, Indians can invest in the Qiagen Nv (QGEN) from India.

With INDmoney, you can buy Qiagen Nv at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Qiagen Nv at zero transaction cost.

How can I buy Qiagen Nv shares from India?

It is very easy to buy Qiagen Nv from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Qiagen Nv be purchased?

Yes, you can buy fractional shares of Qiagen Nv with INDmoney app.

What are the documents required to start investing in Qiagen Nv stocks?

To start investing in Qiagen Nv, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.